You are here

Article Text

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Correspondence on: ‘Warfarin use and risk of knee and hip replacements’’ by He et al
Free
  1. Priyanka Ballal1,
  2. Christine Peloquin2,
  3. Cindy Germaine Boer3,
  4. Tuhina Neogi4
  1. 1 Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA
  2. 2 Clinical Epidemiology Unit, Boston University, Boston, Massachusetts, USA
  3. 3 Internal Medicine, Genetic Laboratories, Erasmus MC, Rotterdam, Netherlands
  4. 4 Section of Rheumatology, Boston University, Boston, Massachusetts, USA
  1. Correspondence to Dr Tuhina Neogi, Section of Rheumatology, Boston University, Boston, MA 2118, USA; tneogi{at}bu.edu

https://doi.org/10.1136/annrheumdis-2021-220855

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank the authors for their interest in our work.1–3 Their approach and results provide yet additional support to the adverse impact of warfarin on osteoarthritis outcomes, as compared with direct oral anticoagulants.

    Data availability statement

    Deidentified data were used for this work. These data are not publicly available. The IMRD dataset used in this work is a subscription-based dataset with a legal contract requiring data to remain onsite and analysed at Boston University Medical Center. We are therefore legally unable to make these data publicly available. We would be able to collaborate with potential external investigators to address research questions of interest if appropriate resources are provided. Investigators may contact IMRD for further information about obtaining data.

    Ethics statements

    Patient consent for publication

    Ethics approval

    Boston University Medical Campus Institutional Review Board (protocol H-32821).

    References

    1. ↵
      2. He N ,
      3. Fang Z ,
      4. Li X
      . Correspondence on: "Warfarin use and risk f knee and hip replacements". Ann Rheum Dis 2023;82:e172. doi:10.1136/annrheumdis-2021-220819
    2. ↵
      2. Ballal P ,
      3. Peloquin C ,
      4. Boer CG , et al
      . Warfarin use and risk of knee and hip replacements. Ann Rheum Dis 2021;80:605–9.doi:10.1136/annrheumdis-2020-219646
      OpenUrlAbstract/FREE Full Text
    3. ↵
      2. Boer CG ,
      3. Szilagyi I ,
      4. Nguyen NL , et al
      . Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis. Ann Rheum Dis 2021;80:598–604.doi:10.1136/annrheumdis-2020-219483
      OpenUrlAbstract/FREE Full Text

    Footnotes

    • Twitter @CurlyGeneticist

    • Contributors PB was involved in drafting the response and critical revision. CP and TN were involved in critical revision.

    • Funding This work and CP were supported by NIH P30AR072571. TN was supported by NIH K24AR070892. Sponsors played no role in the conduct of the study or preparation of this manuscript.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles